Article Figures & Tables
Tables
- Table 1:
Characteristics of cohort receiving therapy for latent tuberculosis infection and untreated cohort
- Table 2:
Event rates and odds ratios for outcomes of interest, by cohort
- Table 3:
Crude risk estimates for any event of interest requiring admission to hospital, by cohort
- Table 4:
Crude risk estimates for hepatic events requiring admission to hospital, by cohort
- Table 5:
Age-stratified crude and adjusted odds ratios of hepatic events requiring hospital admission that were followed by premature cessation of isoniazid therapy
In this issue
Article tools
Respond to this article
Jump to section
Related Articles
Cited By...
- Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study
- Benefit of treatment of latent tuberculosis infection in individual patients
- Current Treatment Options for Latent Tuberculosis Infection
- People aged above 65 treated for latent tuberculosis are at increased risk of admission for a hepatic event compared with untreated controls
More in this TOC Section
Similar Articles
